Simplex Trading’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,012
Closed -$125K 9427
2025
Q2
$150K Buy
+2,012
New +$133K ﹤0.01% 4799
2024
Q3
Sell
-251
Closed -$20.3K 8918
2024
Q2
$20K Buy
+251
New +$22.1K ﹤0.01% 6883
2023
Q4
Sell
-2,712
Closed -$234K 9199
2023
Q3
$242K Buy
+2,712
New +$242K ﹤0.01% 4156
2022
Q4
Sell
-1,495
Closed -$120K 9649
2022
Q3
$110K Sell
1,495
-15,902
-91% -$1.14M ﹤0.01% 5383
2022
Q2
$1.13M Buy
17,397
+16,607
+2,102% +$983K ﹤0.01% 2483
2022
Q1
$49K Sell
790
-1,809
-70% -$98.4K ﹤0.01% 7150
2021
Q4
$137K Buy
+2,599
New +$158K ﹤0.01% 5740
2020
Q4
Sell
-645
Closed -$69.4K 8612
2020
Q3
$56K Sell
645
-8,043
-93% -$703K ﹤0.01% 5503
2020
Q2
$778K Buy
+8,688
New +$878K ﹤0.01% 2384
2020
Q1
Sell
-396
Closed -$42.9K 7836
2019
Q4
$45K Buy
+396
New +$47.9K ﹤0.01% 5286
2019
Q1
Sell
-272
Closed -$24.7K 7375
2018
Q4
$27K Sell
272
-484
-64% -$50.8K ﹤0.01% 5086
2018
Q3
$86K Buy
+756
New +$78.3K ﹤0.01% 4586

Other funds holding HAE

Simplex Trading's HAE Position: Q3 2025 in Review

Simplex Trading sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 2,012 shares — an estimated $125K sold.

Simplex Trading first reported a position in HAE in Q3 2018 and held it in 12 quarters. The position peaked at $1.13M in Q2 2022. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Simplex Trading reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,012 Haemonetics shares in Q3 2025, an estimated $125K.
  • Simplex Trading first reported a position in Haemonetics in Q3 2018 and held it in 12 quarters.
  • Simplex Trading's Haemonetics position peaked at $1.13M in Q2 2022.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.